Skip to main content
MedPathMedPath Home
Clinical Trials/TCTR20230603002
TCTR20230603002
Completed
Not Applicable

Head-to-Head Comparison of 18F FDG and 18F FES PET/CT for Initial Staging of ER-Positive Breast Cancer Patients.

ational Cyclotron and PET Centre, Chulabhorn Hospital0 sites206 target enrollmentJune 3, 2023
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsInitial staging in ER-positive breast cancer18F-FDG, 18F-FES, 18F-Fluorodeoxyglucose, 18F-Fluroestradiol, ER-positive breast cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Initial staging in ER-positive breast cancer
Sponsor
ational Cyclotron and PET Centre, Chulabhorn Hospital
Enrollment
206
Status
Completed
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 3, 2023
End Date
October 28, 2022
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
ational Cyclotron and PET Centre, Chulabhorn Hospital

Eligibility Criteria

Inclusion Criteria

  • •(i) patients with pathologically confirmed breast cancer with estrogen receptor (ER) positive and (ii) patients who were \> 18 years old

Exclusion Criteria

  • •(i) patients with fasting blood sugar more than 200 mg/dL; (ii) patients who has history of other cancer; (iii) patients with known ER negative, (iv) patients with unknown ER status; and (iii) patients who were pregnant or during breast feed.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Not Applicable
A comparative study of F-18 FBPA-PET and F-18 FDG-PET in head and neck cancerHead and neck cancer
JPRN-UMIN000049242Osaka University Graduate School of Medicine85
Completed
Not Applicable
To evaluate and compare the efficacy of 18F-FDG PET taken in hyperglycemic state, 18F-FDG PET taken in NPO state, and C-11 acetate PET in detecting and grading brain tumorNeoplasms
KCT0004466Yonsei University Health System, Severance Hospital73
Active, not recruiting
Phase 1
Diagnostic comparison of 18F-FDG with 18F-FAPI-74 in Thyroid Cancer patients with TENIS SyndromeImaging comparison of the drug under investigation on thyroid cancer patients with TENIS syndromeTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2021-002904-11-CYGERMAN ONCOLOGY CENTER20
Unknown
Not Applicable
Prospective Comparison of 18F-FDG and 18F-FET PET for Response Evaluation in Patients With Primary Central Nervous System LymphomaPatients With Suspected or Diagnosed Central Nervous System Lymphoma
NCT05083936Asan Medical Center30
Completed
Not Applicable
11C-MET PET(/CT) vs 18F-FDG PET(/CT) in the follow-up of differentiated thyroid cancer*
NL-OMON32909niversitair Medisch Centrum Groningen40